Application Sponsors
ANDA 212706 | SLAYBACK PHARMA LLC | |
Marketing Status
Application Products
001 | CAPSULE;ORAL | 0.02MG;1MG | 0 | MERZEE | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-12-18 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
SLAYBACK PHARMA LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 212706
[companyName] => SLAYBACK PHARMA LLC
[docInserts] => ["",""]
[products] => [{"drugName":"MERZEE","activeIngredients":"ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","strength":"0.02MG;1MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"12\/18\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-12-18
)
)